The Cigna Group (NYSE:CI) Q2 2024 Earnings Conference Call August 1, 2024 8:30 AM ET
Company Participants
Ralph Giacobbe - SVP of IR
David Cordani - Chairman and CEO
Brian Evanko - CFO, and President and CEO, Cigna Healthcare
Eric Palmer - President and CEO, Evernorth Health Services
Conference Call Participants
Justin Lake - Wolfe Research
Lisa Gill - JPMorgan
A.J. Rice - UBS
Andrew Mok - Barclays
Scott Fidel - Stephens
Ryan Langston - TD Cowen
Josh Raskin - Nephron Research
George Hill - Deutsche Bank
Erin Wright - Morgan Stanley
Stephen Baxter - Wells Fargo
Dave Windley - Jefferies
Jessica Tassan - Piper Sandler
Lance Wilkes - Bernstein
Operator
Ladies and gentlemen, thank you for standing by for the Cigna Group Second Quarter 2024 Results Review. At this time all callers are in listen-only mode. We will conduct a question-and-answer session later during the conference. [Operator Instructions] As a reminder, ladies and gentlemen, this conference, including the Q&A session, is being recorded.
We'll begin by turning the call over to Ralph Giacobbe. Please go ahead.
Ralph Giacobbe
Thank you. Good morning, everyone. Thanks for joining today's call. I'm Ralph Giacobbe, Senior Vice President of Investor Relations. With me on the line this morning are David Cordani, the Cigna Group's Chairman and Chief Executive Officer; Brian Evanko, Chief Financial Officer of the Cigna Group and President and Chief Executive Officer of Cigna Healthcare; and Eric Palmer, President and Chief Executive Officer of Evernorth Health Services.
In our remarks today, David and Brian will cover a number of topics, including our second quarter financial results and our financial outlook for 2024. Following their prepared remarks, David, Brian and Eric will be available for Q&A. As noted in our earnings release, when describing our financial results, we use certain financial measures, including adjusted income from operations and adjusted revenues, which are not determined in accordance with accounting principles generally, accepted in the United States, otherwise known as GAAP.
A reconciliation of these measures to the most directly comparable GAAP measures, shareholders net income and total revenues, respectively, is contained in today's earnings release, which is posted in the Investor Relations section of the cignagroup.com. We use the term labeled adjusted income from operations and adjusted earnings per share on the same basis as our principal measures of financial performance.
In our remarks today, we will be making some forward-looking statements, including statements regarding our outlook for 2024 and future performance. These statements are subject to risks and uncertainties that could cause actual results to differ materially from our current expectations.